Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) — North America Leads Today, Asia Pacific to Record Fastest Growth
The global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to advance at a resilient CAGR of 11.8% from 2024 to 2029, culminating in a forecasted valuation of US$50.2 billion by the end of the period. This growth is propelled by surging R&D investments in drug discovery, strategic government funding, and the increasing adoption of automation in life sciences research.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950
What Is Driving the Market Now?
HTS adoption is accelerating due to innovations in automation, miniaturization, and high-content screening, which significantly reduce discovery timelines and enhance precision in identifying therapeutic candidates. Grants such as the USD 7.8 million awarded to the University of Pittsburgh for advanced drug discovery systems underscore growing institutional and government commitment to high-impact research.
Why Does This Matter for Global Pharma and Biotech Leaders?
The market represents a critical enabler for competitive advantage in lead discovery, target validation, compound profiling, and hit identification—processes essential for pipeline acceleration. While high instrument costs remain a barrier, particularly for automated liquid handling and high-resolution imaging systems, emerging markets such as China and India offer lucrative opportunities with strong government support and an expanding pharmaceutical manufacturing base.
Who Are the Key Stakeholders?
The HTS ecosystem spans pharmaceutical giants, biotechnology innovators, academic institutions, and technology providers, all collaborating to enhance assay development and manage the rising complexity of biological data. The consumables segment—driven by recurring purchases of reagents and kits—dominates the market, ensuring steady demand as HTS workflows expand globally.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950
Where Is Growth Coming From? North America currently leads, fueled by advanced HTS infrastructure, robust funding for life science research, and a thriving biotech sector.
Asia Pacific is projected to be the fastest-growing region, supported by a diverse patient base, strong pharmaceutical capabilities, and favorable regulatory environments.
How Are Market Leaders Responding? Thermo Fisher Scientific Inc. maintains global leadership through an extensive portfolio of automated systems, screening instruments, and consumables, underpinned by 3% annual R&D investment and strategic alliances.
Agilent Technologies, Inc. offers highly customizable workflows via BioTek detection instruments and Gen6 software, strengthened by acquisitions such as e-MSion (US) to enhance mass spectrometry capabilities.
Merck KGaA delivers a diverse portfolio of reagents, instruments, software, and services, leveraging global reach and deep customer relationships across pharma, academia, and government sectors.
Market Outlook
As automation, AI-driven data analysis, and advanced assay development converge, HTS will remain at the forefront of pharmaceutical innovation. Decision-makers who strategically invest in HTS capabilities today will be best positioned to accelerate therapeutic pipelines, capture market share, and deliver faster, more targeted treatments to market.
For more information, Inquire Now
Discover Connected Healthcare Market Opportunities:
Drug Screening Market
Carrier Screening Market
Cell based Assays Market
Label Free Detection Market
Life Science Instrumentation Market
Get access to the latest updates on High-Throughput Screening Companies and High-Throughput Screening Market Size
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
U.S. FACTORY PURCHASES SLOWED SHARPLY IN JULY, DRIVING GLOBAL SUPPLY CHAIN SLOWDOWN: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
U.S. manufacturers slash purchases after front-loading inventories during the 'tariff pause' Asia factories slow, driven by Japan, South Korea and Taiwan manufacturers Europe's fragile recovery stalled in July as German growth weakened ahead of tariff agreements CLARK, N.J., Aug. 13, 2025 /CNW/ -- Global supply chain activity fell in July as U.S. manufacturers sharply tapered purchases of materials and components after building inventories in June ahead of the end of the 'tariff pause,' according to the GEP Global Supply Chain Volatility Index, a leading indicator tracking demand conditions, shortages, transportation costs, inventories, and backlogs based on a monthly survey of 27,000 businesses. The index dropped to -0.35 from -0.17 in June, signaling increased spare capacity worldwide. The U.S. was the main driver, with North America's index falling to -0.33 from -0.06. The reversal follows a surge in June when U.S. factories front-loaded orders to beat anticipated tariff changes. In July, U.S. manufacturers sharply tapered purchases of inputs — materials, components and commodities — signaling expectations of slowing demand going forward. "When we remove companies' front-loading inventories and rerouting goods to avoid tariffs, the underlying picture points to slowing manufacturing demand worldwide," said John Piatek, vice president, consulting, GEP. "The July data shows a clear pullback in orders, with U.S. manufacturers preparing for lower demand going forward." REGIONAL KEY FINDINGS Asian factory purchasing activity remains slightly below trend due to growing weakness in Japan and South Korea. Data was mostly collected prior to these two countries striking double-digit tariff agreements with the U.S. Taiwanese factories also saw an accelerated downturn, weighing on the broader region. Notably, after declining in the two previous months, China's factory buying volumes rose in July. Europe industrial recovery slipped: Its index dropped to -0.30 from 0.01. Germany's rebound slowed, highlighting the fragile nature of the continent's industrial recovery. U.K.: Index declined to -0.58, from -0.41, signaling that the U.K.'s supply chains continue to experience an elevated level of spare capacity. Interpreting the data:Index > 0, supply chain capacity is being stretched. The further above 0, the more stretched supply chains < 0, supply chain capacity is being underutilized. The further below 0, the more underutilized supply chains are. CATEGORY KEY FINDINGS INVENTORIES: Safety stockpiling eased, indicating limited concern over supply bottlenecks or price surges. LABOR & TRANSPORTATION: Staffing capacity and transportation costs were stable, with no signs of inflationary pressure from these sources. For more information, visit Note: Full historical data dating back to January 2005 is available for subscription. Please contact economics@ The next release of the GEP Global Supply Chain Volatility Index will be 8 a.m. ET, Sep. 11, 2025. About the GEP Global Supply Chain Volatility Index The GEP Global Supply Chain Volatility Index is produced by S&P Global and GEP. It is derived from S&P Global's PMI® surveys, sent to companies in over 40 countries, totaling around 27,000 companies. The headline figure is a weighted sum of six sub-indices derived from PMI data, PMI Comments Trackers and PMI Commodity Price & Supply Indicators compiled by S&P Global. A value above 0 indicates that supply chain capacity is being stretched and supply chain volatility is increasing. The further above 0, the greater the extent to which capacity is being stretched. A value below 0 indicates that supply chain capacity is being underutilized, reducing supply chain volatility. The further below 0, the greater the extent to which capacity is being underutilized. A Supply Chain Volatility Index is also published at a regional level for Europe, Asia, North America and the U.K. For more information about the methodology, click here. About GEP GEP® delivers AI-powered procurement and supply chain solutions that help global enterprises become more agile and resilient, operate more efficiently and effectively, gain competitive advantage, boost profitability and increase shareholder value. Fresh thinking, innovative products, unrivaled domain expertise, smart, passionate people — this is how GEP SOFTWARE™, GEP STRATEGY™ and GEP MANAGED SERVICES™ together deliver procurement and supply chain solutions of unprecedented scale, power and effectiveness. Our customers are the world's best companies, including more than 1,000 Fortune 500 and Global 2000 industry leaders who rely on GEP to meet ambitious strategic, financial and operational goals. A leader in multiple Gartner Magic Quadrants, GEP's cloud-native software and digital business platforms consistently win awards and recognition from industry analysts, research firms and media outlets, including Gartner, Forrester, IDC, ISG, and Spend Matters. GEP is also regularly ranked a top procurement and supply chain consulting and strategy firm, and a leading managed services provider by ALM, Everest Group, NelsonHall, IDC, ISG and HFS, among others. Headquartered in Clark, New Jersey, GEP has offices and operations centers across Europe, Asia, Africa and the Americas. To learn more, visit About S&P Global S&P Global (NYSE: SPGI) S&P Global provides essential intelligence. We enable governments, businesses and individuals with the right data, expertise and connected technology so that they can make decisions with conviction. From helping our customers assess new investments to guiding them through ESG and energy transition across supply chains, we unlock new opportunities, solve challenges and accelerate progress for the world. We are widely sought after by many of the world's leading organizations to provide credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help the world's leading organizations plan for tomorrow, today. Media Contacts Derek Creevey Joe Hayes S&P Global Market Intelligence Director, Public Relations Principal Economist Corporate Communications GEP S&P Global Market Intelligence Email: Phone: +1 646-276-4579 Phone: +44-1344-328-099Email: Email: View original content to download multimedia: SOURCE GEP View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
8 minutes ago
- Bloomberg
Bessent Says Fed Rates Should Likely Be 150, 175 Basis Points Lower
By , Jonathan Ferro, and Annmarie Hordern Save US Treasury Secretary Scott Bessent said interest rates are 'too constrictive' and should likely be 150-175 basis points lower. Bessent, speaking in an interview on Bloomberg Television, said the Federal Reserve could be heading into a series of rate cuts in the coming months — starting with a half-point reduction in September.
Yahoo
35 minutes ago
- Yahoo
[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD 24.58 Billion in 2024 and is expected to reach USD 30.76 Billion in 2025 and is expected to reach around USD 192.95 Billion by 2034, at a CAGR of 28.63% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Ginkgo Bioworks, Amyris, Thermo Fisher Scientific, Illumina, GenScript, Synthetic Genomics, Novozymes, LanzaTech, Zymergen, Twist Bioscience, Codexis, Cambrian Biopharma, Moderna, Editas Medicine, Vertex Pharmaceuticals, CRISPR Therapeutics, Arbor Biotechnologies, Synthego, Evonik Industries, Cargill, Others and others. Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'AI in Synthetic Biology Market Size, Trends and Insights By Technology (Gene Synthesis, Genome Editing, Synthetic Biology Tools, Bioinformatics), By Application (Healthcare & Medicine, Agricultural Biotechnology, Industrial Biotechnology, Environmental Biotechnology), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database. 'According to the latest research study, the demand of global AI in Synthetic Biology Market size & share was valued at approximately USD 24.58 Billion in 2024 and is expected to reach USD 30.76 Billion in 2025 and is expected to reach a value of around USD 192.95 Billion by 2034, at a compound annual growth rate (CAGR) of about 28.63% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global AI in Synthetic Biology Market @ Overview As per the industry experts at CMI, the main growth driver for the synthetic biology market is the growing demand for sustainable solutions in various industries. As the focus on the environment intensifies, synthetic biology has a bio-based solution to this problem that might be petrochemical-related. Synthetic biology provides solutions like biofuels, biodegradable plastics, and environmentally friendly chemicals. Education and the discovery of gene editing and biotechnology, as appealing new developments on the landscape of synthetic biology, create opportunities for exceptional innovations in exciting areas, such as moving forward in healthcare and agriculture. The interest in personalized medicine is part of this trend, along with interest in genetically modified crops and in bio-manufactured products. Together, these possibilities combine to help with the rapid expansion of the market. Key Trends & Drivers Growth of Technologies: The advances in technologies related to genetic engineering, particularly in CRISPR and genome editing technologies, are a significant driver of growth in the synthetic biology market. Advances in genetic engineering provide more accuracy in making genetic modifications, leading to integrative breakthroughs in healthcare, agriculture, and the sustainability of the environment. The increasing efficiency and accessibility of these tools will drive innovation, such as gene therapies and a developable path for genetically modified crops and sustainable biofuels, leading to synthetic biology market growth. Increase in Demand for Sustainable AIternatives: There is also a government- and socially oriented push for sustainable alternatives that is driving the synthetic biology market. The continued increases in demand by consumers globally for sustainable alternatives to petrochemical products will also lead to increases in market awareness. Synthetic biology is providing not only biofuels but also biodegradable plastics and renewable chemicals that provide sustainable alternatives to any need for sustainable solutions to meet environmental, waste management, and greenhouse gas emissions, while also providing industrial biotechnology and renewable energy solutions. Healthcare Innovations: Synthetic biology is changing the healthcare field with advances like gene therapies, biologics, and personalized medicine. Innovations in gene editing and building new therapeutic proteins will make it possible to treat previously considered untreatable genetic disorders. As these types of technologies develop, they will provide huge growth in healthcare markets, especially personalized medicine and regenerative medicine. Request a Customized Copy of the AI in Synthetic Biology Market Report @ Regulatory Challenges: The synthetic biology market has many regulatory challenges, as the regulatory environment is complex, evolving, and different across different countries and is particularly about genetically modified organisms (GMOs) and bioengineering products, which can cause uncertainty for companies and delayed product development. New regulatory restrictions or changes to the public's acceptance of genetically modified products could lead to transformed market growth and increased operating costs for companies in products or in the cleaning and sourcing of raw materials, which will offset the overall market trend. Ethics and Social Issues: Increasing public concern about the ethical concerns related to synthetic biology, particularly the risks associated with genetic modification and biohacking, is impacting market forces. There is ongoing discussion about the safety, transparency, and long-term consequences for the environment associated with synthetic biology applications. These concerns could lead to increased regulations and social pushback, which could also impact acceptance from consumers and overall market acceptance. High Research & Development and Manufacturing Costs: Defining characteristics of the synthetic biology market are high R&D, development, and manufacturing costs. The activity associated with creating genetically engineered organisms or synthetic materials requires considerable investment of time and capital in R&D, technical capacity, and skilled human resources. Such activity is an excessive burden for small companies and has the potential to slow down the speed at which innovations are scaled, hampering latent market growth and access to developing technologies. Report Scope Feature of the Report Details Market Size in 2025 USD 30.76 Billion Projected Market Size in 2034 USD 192.95 Billion Market Size in 2024 USD 24.58 Billion CAGR Growth Rate 28.63% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Technology, Application and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the AI in Synthetic Biology report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the AI in Synthetic Biology report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the AI in Synthetic Biology Market Report @ SWOT Analysis Strengths: Synthetic biology is poised for powerful growth as advances in gene editing and biotechnology continue to drive innovation. Because synthetic biology offers sustainable solutions, including biofuels and biodegradable plastics, the industry will align with global goals and commitment to a sustainable environment. Synthetic biology offers advances in medical technology with the emergence of personalized medicines. Synthetic biology has strong economic support from private investment, as well as global government investment, all of which provides an ecosystem that bolsters innovation and commercialization, helping to maintain the sector's preferred market position. Weaknesses: The high level of research, development, and manufacturing costs remains a basic barrier in synthetic biology. Because making genetic modifications is complex, requiring a high level of expertise and equipment, this represents a financial burden, particularly for smaller firms. Rules and regulations that slow progress in accelerating approval in some areas of the world are also a barrier to faster entry into the market. The industry also relies on highly specialized technologies, which create barriers to entry for new players, limiting the competition. Opportunities: The trends in sustainable, eco-friendly solutions are yielding opportunities for significant growth. Synthetic biology stands poised to change the production of renewable energy, biodegradable materials, and bio-based chemicals to decrease reliance on fossil fuels. In healthcare, gene therapy and personalized medicine allow emerging approaches to addressing genetic disorder diagnosis. Growing consumer interest and demand for cleaner products, coupled with government support for green technologies, will create an optimal environment for new markets in synthetic biology to expand. Threats: The synthetic biology space faces unique threats that could alter the ability to grow the market. First are threats from regulations and ethical concerns related to genetic modifications. If regulations for testing and obtaining approval for products, especially for GMOs and bio-engineering applications, are strict, this could slow down product development and raise the cost to enter and sell products in the synthetic biology markets. Second, public skepticism about the safety associated with GMOs and bio-hacking poses an additional threat to consumer acceptance. Finally, competition from traditional industries, along with escalating costs of research and development and financing growth with debt or equity, creates uncertainty around sustainable growth in the market and scaling production for accepted consumer products. Request a Customized Copy of the AI in Synthetic Biology Market Report @ Key questions answered in this report: What is the size of the AI in Synthetic Biology market and what is its expected growth rate? What are the primary driving factors that push AI in the synthetic biology market forward? What are the AI in Synthetic Biology Industry's top companies? What are the different categories that the AI in Synthetic Biology Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What steps must be followed to obtain a free copy of the AI in Synthetic Biology market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium AI in Synthetic Biology Research Report | Fast Delivery Available - [220+ Pages] @ Regional Analysis The AI in Synthetic Biology Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region: North America: Synthetic food, films, fertilizers, drugs, fuels, etc., as biobased products, is the biggest part of the synthetic biology market's sheer economic growth area over biobased chemicals and pharmaceuticals. The amount of investment and emergence of new start-ups, particularly in the US, is evidence of the breadth and depth of the market. North America is perhaps the strongest region with regard to all aspects relating to synthetic biology, as well as the former. North America is the headquarters of several early entrants, Ginkgo Bioworks and Amyris being two retail applicators. The US government and other North American countries have become biocompatible with regard to funding biotechnology research. Above all, North America's funding, regulation, and support of research and development have provided a speedier platform for advances in health care as well as agriculture, industrial biotechnology, etc. In addition, North America leads not only in the regulation and support of research and development but also in data and technological adoption and licensing compared to other regions. Market maturity will drive growth over geographies. Current trends are driving the growth of the synthetic biology market in North America. In healthcare, e.g., gene therapy is at the forefront of developments in clinical, regulatory, and reimbursement pathways. Sustainable bio-manufacturing is gaining ground on traditional manufacturing and chemical processing systems, especially on a local or regional level. Europe: Europe has made significant strides in advanced research programs involving synthetic biology processes and materials due to a diversity of innovation drivers and public and private organisations that stimulate take-up action. The emerging European market for synthetic biology has experienced a rapid increase in both investment and engagement related to publicly and privately funded research and development, alongside strong regulatory and ethical frameworks that can accelerate the introduction of new products and solutions. The emergence of different-staged external-partner organisations in the UK, Germany, and France, and their collaborative arrangements, is the source of many, if not most, overall synthetic bioproduction innovations. The funding from the European Union's Horizon 2020 program has also contributed to the overall development of synthetic biology processes. While the market is at a diverse growth stage, the interrelatedness between each of the levels of action related to synthetic biology products and materials provides a stable path whereby the activity between academia, various types of industries, and government/regulation remains intertwined. Growth in research and collaboration across a diversity of public and private partner players is promoting continued diverse innovations with synthetic biology and biofuels, biodegradable plastics, and genetically modified crops. Europe has also supported investment and research into sustainable biomanufacturing processes to address these initiatives to reduce the carbon footprint as well as redirect inefficient chemical manufacturing in the region. Asia-Pacific: Asia-Pacific is experiencing rapid advances in synthetic biology, with China and India becoming significant contenders in the market. With a huge population, booming biotechnology sector, and government support for innovation, the Asia-Pacific region sees vast potential and demand for genetically modified crops and sustainable biomanufacturing solutions. China is making huge investments in synthetic biology research and development, and it already has a larger presence in the global biotech market. China is emerging as a focal point for developments in genome editing and gene synthesis. India has a rapidly advancing agricultural biotechnology sector and is seeing rapid growth in healthcare as well. The growth of bio-based chemicals will be a significant opportunity for the Asia-Pacific region, as will the use of synthetic biology for sustainable solutions. LAMEA (Latin America, Middle East, and Africa): Synthetic biology in LAMEA is still emerging, with growth potential on the horizon. For example, synthetic biology has opened up avenues for import and export with countries in Latin America, which are focused almost solely on agricultural biotechnology and biofuels. As they leverage synthetic biology for food security and increased crop yields, in combination with how synthetic biology contributes to sustainable energy, many countries are interested in the potential of synthetic biology. The Middle East region is investing in biomanufacturing and biotechnology as part of its diversification and shift away from oil-dependent economic ventures. Lastly, Africa is also beginning to develop in the area of synthetic biology, with growth especially focused on healthcare and agricultural (about food security) solutions. Request a Customized Copy of the AI in Synthetic Biology Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'AI in Synthetic Biology Market Size, Trends and Insights By Technology (Gene Synthesis, Genome Editing, Synthetic Biology Tools, Bioinformatics), By Application (Healthcare & Medicine, Agricultural Biotechnology, Industrial Biotechnology, Environmental Biotechnology), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at List of the prominent players in the AI in Synthetic Biology Market: Ginkgo Bioworks Amyris Thermo Fisher Scientific Illumina GenScript Synthetic Genomics Novozymes LanzaTech Zymergen Twist Bioscience Codexis Cambrian Biopharma Moderna Editas Medicine Vertex Pharmaceuticals CRISPR Therapeutics Arbor Biotechnologies Synthego Evonik Industries Cargill Others Click Here to Access a Free Sample Report of the Global AI in Synthetic Biology Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: High Flow Nasal Cannula Market: High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single Heated Tube, Nasal Cannula, Active Humidifier, Air Blender), By Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart Failure, Others), By End User (Hospitals and Clinics, Ambulatory Care Centers, Long-term Care Centers, Others), By Sales Channel (Direct Channel, Indirect Channel), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 US Pharmaceutical Drug Delivery Market: US Pharmaceutical Drug Delivery Market Size, Trends and Insights By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other), By Application (Cardiovascular Diseases, Diabetes, Cancer, Infectious Diseases, Others), By End-user (Hospitals, Ambulatory Services, Home Healthcare), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Peptide Cancer Vaccine Market: Peptide Cancer Vaccine Market Size, Trends and Insights By Type (Multivalent Peptide Vaccine, Peptide Cocktail Type, Personalized Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine, Hybrid Peptide Vaccine), By Application (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Neoantigen Cancer Vaccine Market: Neoantigen Cancer Vaccine Market Size, Trends and Insights By Product (Personalised antigen vaccine, Off-the-shelf neoantigen vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic acid, Dendritic cell, Tumour cell), By Route of Administration (Intravenous, Intramuscular, Transdermal), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Non-invasive Brain Trauma Monitoring Device Market: Non-invasive Brain Trauma Monitoring Device Market Size, Trends and Insights By Product Type (Monitoring Devices, Consumables), By End-User (Hospitals, Neurological Centres, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Burial Insurance Market: Burial Insurance Market Size, Trends and Insights By Coverage (Level Death Benefit, Guaranteed Acceptance, Modified or Graded Death Benefit), By End Use (Over 50, Over 60, Over 70, Over 80), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Organoids and Spheroids Market: Organoids and Spheroids Market Size, Trends and Insights By Organoids Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), By Spheroids Type (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), By Organoids Source (Primary Tissues, Stem Cells), By Spheroids Source (Cell Line, Primary Cell, iPSCs Derived Cells), By End User (BioSource and Pharmaceutical Industries, Academic & Research Institutes, Hospitals and Diagnostic Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Medical Education Market: Medical Education Market Size, Trends and Insights By Delivery Mode (Classroom-based Training, E-learning Solutions, Online Learning, Simulation-based Learning, AR/VR-based Training, AI-powered Learning), By End User Type (Medical Schools and Universities, Hospitals and Healthcare Organizations, Independent Training Institutes), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 The AI in Synthetic Biology Market is segmented as follows: By Technology Gene Synthesis Genome Editing Synthetic Biology Tools Bioinformatics By Application Healthcare & Medicine Agricultural Biotechnology Industrial Biotechnology Environmental Biotechnology Click Here to Get a Free Sample Report of the Global AI in Synthetic Biology Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This AI in Synthetic Biology Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who are the global key players in this AI in the synthetic biology market? What are the profiles, product details, and contact information for these companies? What Was the Global Market Status of the AI in Synthetic Biology Market? What Was the Capacity, Production Value, Cost and PROFIT of the AI in Synthetic Biology Market? What Is the Current Market Status of the AI in Synthetic Biology Industry? What's the market's competition in this industry, both company-wise and country-wise? What's Market Analysis of AI in Synthetic Biology Market by Considering Applications and Types? What Are Projections of the Global AI in Synthetic Biology Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is AI in Synthetic Biology Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On AI in Synthetic Biology Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of AI in Synthetic Biology Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for AI in Synthetic Biology Industry? Click Here to Access a Free Sample Report of the Global AI in Synthetic Biology Market @ Reasons to Purchase AI in Synthetic Biology Market Report AI in Synthetic Biology Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. AI in Synthetic Biology Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. AI in Synthetic Biology Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. The report includes extensive company profiles, which include company overviews, insights, product benchmarking, and SWOT analyses for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. AI in Synthetic Biology Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global AI in Synthetic Biology market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established leaders drive market growth. Buy this Premium AI in Synthetic Biology Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide AI in Synthetic Biology market analysis. The report covers the competitive environment of current and potential participants in the AI in Synthetic Biology market, along with those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report provides comparable data for the key regions. The report provides actual market sizes and forecasts for each segment mentioned above. Who should buy this report? Participants and stakeholders worldwide AI in Synthetic Biology market should find this report useful. The research will be useful to all market participants in the AI in Synthetic Biology industry. Managers in the AI in Synthetic Biology sector are interested in publishing up-to-date and projected data about the worldwide AI in Synthetic Biology market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in AI in Synthetic Biology products' market trends. Analysts, researchers, educators, strategy managers, and government organizations seek market insights to develop their plans. Request a Customized Copy of the AI in Synthetic Biology Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium AI in Synthetic Biology Research Report | Fast Delivery Available - [220+ Pages] @ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
